Will SentinelOne report net new ARR below $45M in any quarter by Q2 FY2027?

Q4 FY2026 net new ARR came in at $64M — a company record and a $10M beat versus Q3's $54M. The buffer above the $45M threshold has widened from $9M to $19M. Management explicitly guided to YoY improvement in net new ARR for FY2027, implying at least $54M+ in every quarter going forward (Q3 FY2026 was $54M, the prior-year comp). The seasonality shift from 40/60 to 50/50 H1/H2 further insulates Q1 FY2027 — historically the weakest quarter — from a catastrophic miss. For this market to resolve YES, net new ARR would need to fall from $64M to below $45M, a 30% sequential collapse, AND management's explicit YoY improvement guidance would need to be violated. The ARR metric retirement risk has also receded: ARR was disclosed in Q4, suggesting SentinelOne intends to keep the metric through the resolution window. The original 30% estimate was predicated on a $9M buffer, decelerating trajectory, and metric retirement uncertainty — all three have improved materially. Residual risk is a macro-driven demand freeze or a large acquired-product churn spike in a single quarter.

The Q4 FY2026 print fundamentally changes the probability structure of this market. Prior probability of 30% was built around a $9M buffer, flat YoY trajectory (+1%), and material ARR metric retirement risk. All three pillars have weakened: (1) Buffer is now $19M. (2) YoY trajectory has reversed — Q4 FY2026 net new ARR was $64M vs $60M in Q4 FY2025, breaking the deceleration trend. (3) ARR was disclosed in Q4, reducing but not eliminating the retirement risk (the company could still stop disclosing in subsequent quarters). The 50/50 seasonality guidance implies Q1 FY2027 net new ARR of approximately $45-55M (half of ~$100M H1 implied by the $200M+ FY2027 guidance). This is uncomfortably close to the $45M threshold for Q1 specifically — a weak Q1 remains the most plausible path to YES. However, management's YoY improvement language would need to be violated, which rarely happens in the quarter immediately following the guidance. I anchor at 12% to reflect the narrow Q1 tail risk while acknowledging the structural improvement.

The record $64M Q4 print combined with management's FY2027 net new ARR improvement guide makes a sub-$45M quarter in the remaining resolution window (Q1 FY2027 and Q2 FY2027) implausible absent a severe macro shock. Consider the implied floor: multi-module adoption surged to 65% at 3+ solutions (from 39% a year ago), Purple AI attach hit 50%+, Data ARR crossed $130M, and Wayfinder crossed $100M. These are compounding platform revenue streams, not cyclical one-time deals. Even if net new ARR were to fall sharply from the $64M record — say, to $50M in a seasonally soft Q1 — it remains $5M above the threshold. A sub-$45M print requires ALL of: organic endpoint deceleration, new product momentum stalling, AND no benefit from the 50/50 seasonality shift management explicitly targeted. This is a tail scenario. The only residual risk is a forced metric retirement mid-FY2027 combined with one quarter that would have been below $45M — but even that requires the demand weakness, not just the reporting change. I assign 9% primarily as uncertainty tax on the 2-quarter remaining window and the historically volatile nature of quarterly ARR metrics.